PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Reducing emissions will be the primary way to fight climate change, UCLA-led study finds

Climate engineering won't sufficiently stem global warming

2014-06-01
(Press-News.org) Forget about positioning giant mirrors in space to reduce the amount of sunlight being trapped in the earth's atmosphere or seeding clouds to reduce the amount of light entering earth's atmosphere. Those approaches to climate engineering aren't likely to be effective or practical in slowing global warming.

A new report by professors from UCLA and five other universities concludes that there's no way around it: We have to cut down the amount of carbon being released into the atmosphere. The interdisciplinary team looked at a range of possible approaches to dissipating greenhouse gases and reducing warming.

"We found that climate engineering doesn't offer a perfect option," said Daniela Cusack, the study's lead author and an assistant professor of geography in UCLA's College of Letters and Science. "The perfect option is reducing emissions. We have to cut down the amount of emissions we're putting into the atmosphere if, in the future, we want to have anything like the Earth we have now."

Still, the study concluded, some approaches to climate engineering are more promising than others, and they should be used to augment efforts to reduce the 9 gigatons of carbon dioxide being released each year by human activity. (A gigaton is 1 billion tons.)

The first scholarly attempt to rank a wide range of approaches to minimizing climate change in terms of their feasibility, cost-effectiveness, risk, public acceptance, governability and ethics, the study appears in the latest issue of the peer-reviewed scholarly journal Frontiers in Ecology and the Environment.

The authors hope the information will help the public and decision-makers invest in the approaches with the largest payoffs and the fewest disadvantages. At stake, the study emphasizes, are the futures of food production, our climate and water security.

Cusack, an authority on forest and soil ecology, teamed up with experts in oceanography, political science, sociology, economics and ethics. Working under the auspices of the National Science Foundation, the team spent two years evaluating more than 100 studies that addressed the various implications of climate engineering and their anticipated effects on greenhouse gases.

Ultimately, the group focused its investigation on the five strategies that appear to hold the most promise: reducing emissions, sequestering carbon through biological means on land and in the ocean, storing carbon dioxide in a liquefied form in underground geological formations and wells, increasing the Earth's cloud cover and solar reflection.

Of those approaches, none came close to reducing emissions as much as conservation, increased energy efficiency and low-carbon fuels would. Technology that is already available could reduce the amount of carbon being added to the atmosphere by some 7 gigatons per year, the team found.

"We have the technology, and we know how to do it," Cusack said. "It's just that there doesn't seem to be political support for reducing emissions."

Of the five options the group evaluated, sequestering carbon through biological means — or converting atmospheric carbon into solid sources of carbon like plants — holds the most promise. One source, curbing the destruction of forests and promoting growth of new forests, could tie up as much as 1.3 gigatons of carbon in plant material annually, the team calculated. Deforestation now is responsible for adding 1 gigaton of carbon each year to the atmosphere.

Improving soil management is another biological means of carbon sequestration that holds considerable promise because soils can trap plant materials that have already converted atmospheric carbon dioxide into a solid form as well as any carbon dioxide that the solids give off as they decompose. Since the dawn of agriculture, tilling land has led to the loss of about half (55 to 78 gigatons) of the carbon ever sequestered in soil, the team reports. But such simple steps as leaving slash — the plant waste left over after crop production — on fields after harvests, so it could be incorporated into the soil, could reintroduce between 0.4 and 1.1 gigatons of carbon annually to soil, the study says. The approach would also improve soil's ability to retain nutrients and water, making it beneficial for additional reasons.

"Improved soil management is not very controversial," Cusack said. "It's just a matter of supporting farmers to do it."

The study also advocates a less familiar form of biological sequestration: the burial of biochar. The process, which uses high temperatures and high pressure to turn plants into charcoal, releases little carbon dioxide into the atmosphere. Under normal conditions, decaying plant life inevitably decomposes, a process that releases carbon dioxide into the atmosphere. But charred plant material takes significantly longer — sometimes centuries — to decompose. So the approach can work to keep carbon that has become bound up in plant life from decaying and respiring as carbon dioxide. And like working slash into the soil, adding biochar to soil can improve its fertility and water retention.

"Charcoal has been used as an agricultural amendment for centuries, but scientists are only now starting to appreciate its potential for tying up greenhouse gases," Cusack said.

But not all biological sequestration would be so beneficial. The researchers evaluated the idea of adding iron to oceans in order to stimulate the growth of algae, which sequesters carbon. The approach ranked as the study's least viable strategy, in part because less than a quarter of the algae could be expected to eventually sink to the bottom of the ocean, which would be the only way that carbon would be sequestered for a long period of time. The study predicted that the rest would be expected to be consumed by other sea life that respire carbon dioxide, which would end up back in the atmosphere. Additionally, increasing the algae blooms would likely wreak havoc by decreasing the oxygen available for other marine life.

The study's second most promising climate engineering strategy, after carbon sequestration, was carbon capture and storage, particularly when the technique is used near where fuels are being refined. CCS turns carbon dioxide into a liquid form of carbon, which oil and coal extraction companies then pump into underground geological formations and wells and cap; millions of tons of carbon are already being stored this way each year. And the approach has the potential to store more than 1 gigaton permanently each year — and up to 546 gigatons of carbon over time — the study says.

However, a liquid carbon leak could be fatal to humans and other animals, and the risk – while minimal – may stand in the way of public acceptance.

"With CCS we're taking advantage of an approach that already exists, and big companies pay for the work out of their own pockets," Cusack said. "The hurdle is public perception. No one wants to live next to a huge underground pool of carbon dioxide that might suffocate them and their children – no matter how small the risk."

Reducing the amount of sunlight that is heating up the atmosphere through measures such as artificially increasing the earth's cloud cover or putting reflectors in outer space ranked as the study's second least viable approach. While cloud seeding is cheap and potentially as effective as improving forestry practices, the approach and its potential impacts are not well enough understood for widespread use, the team concluded.

"Cloud seeding sounds simple," Cusack said. "But we really don't understand what would happen to the climate if we started making more clouds."

INFORMATION: Cusack's collaborators were Jonn Axsen, assistant professor of resource and environmental management at Simon Fraser University in British Columbia, Canada; Lauren Hartzell-Nichols, acting assistant professor in the program on values in society and the program on environment at the University of Washington; Katherine Mackey, a postdoctoral researcher at Woods Hole Oceanographic Institution and the Marine Biological Laboratory in Woods Hole, Mass.; Rachael Shwom, assistant professor in human ecology at Rutgers University; and Sam White, assistant professor of environmental history at Ohio State University.


ELSE PRESS RELEASES FROM THIS DATE:

ALTTO test of dual HER2 blockade finds single agent remains the gold standard

2014-06-01
CHICAGO — June 1, 2014 — In the largest clinical trial testing the effectiveness of one versus two drugs to treat HER2-positive breast cancer, lapatinib (Tykerb) did not add benefit to the standard trastuzumab (Herceptin) adjuvant therapy, researchers report at the 50th annual meeting of the American Society of Clinical Oncology (ASCO). MULTIMEDIA ALERT: Video and audio are available for download on the Mayo Clinic News Network. Results of the phase III clinical trial, ALTTO (Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization study), demonstrated that adding ...

The ethics of knowing where to stop treatment in a sick and elderly patient

2014-06-01
An Emeritus Professor of medical ethics at Imperial College London will deliver a presentation at this year's Euroanaesthesia meeting titled 'Escalating care for the comorbid elderly-where do we stop?". Raanan Gillon, who is President of the UK's Institute of Medical Ethics, will argue that a patient's age should not in itself be considered an ethically relevant criterion for deciding 'where to stop'. Acknowledging that there is a morally plausible counter-argument – known in the UK as 'the fair innings argument'- according to which scarce life prolonging resources should ...

Study of 55 million people adds further evidence that patients admitted to hospital at weekends have higher mortality

2014-06-01
A systematic review and meta-analysis of hospital data worldwide, presented as this year's Euroanaesthesia meeting in Stockholm, adds further evidence that patients admitted to hospital at weekends have higher mortality than those admitted on weekdays. The study is by Dr Hiroshi Hoshijima, Tohoku University, Sendai, Japan, and colleagues. The analysis included 72 studies from various world regions, covering 55,053,719 participants. The authors found that weekend admission was associated with increased morality of between 15% and 17% depending on the statistical technique ...

Risk of death highest following surgery in afternoons, at weekends, and in February

2014-06-01
New research presented at this year's Euroanaesthesia show that on weekends, in the afternoons and in February are the times when the risk of death following surgery is the highest. The research is by Dr Felix Kork and Professor Claudia Spies, Charité - University Medicine Berlin, Germany and colleagues. Hospital mortality is subject to day-night, weekly and seasonal variability. This has been shown for various populations, settings, and in different regions of the world. However, a cyclic influence on hospital mortality has not been shown in patients after surgery. ...

Poor coverage of specific gene sets in exome sequencing gives cause for concern

2014-06-01
With services based on exome sequencing becoming affordable to patients at a reasonable price, the question of the quality of the results provided has become increasingly important. The exome is the DNA sequence of genes that are translated into protein. These protein-coding regions contain most of the currently-known disease-causing genetic mutations. The American College of Medical Genetics and Genomics (ACMG) has recommended the reporting to patients of clinically actionable incidental genetic findings in the course of clinical exome testing. Specifically, mutations ...

Responses with crizotinib in MET-amplified lung cancer show new targetable form of disease

2014-05-31
A study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2014 reports the results of a first-in-human, phase 1 dose escalation trial of crizotinib (XALKORI) in 14 patients with advanced, MET-amplified non-small cell lung cancer (NCT00585195). In 2011, the drug crizotinib earned accelerated approval by the US FDA to target the subset of advanced non-small cell lung cancers caused by rearrangements of the anaplastic lymphoma kinase (ALK) gene, and subsequently was granted regular approval in 2013. The drug also has shown dramatic responses in ...

Results in Phase I trial of OMP-54F28, a Wnt inhibitor targeting cancer stem cells

2014-05-31
At the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), University of Colorado Cancer Center researchers reported results of a Phase I trial of OMP-54F28 (FZD8-Fc), an investigational drug candidate discovered by OncoMed Pharmaceuticals targeting cancer stem cells (CSCs). The drug was generally well tolerated, and several of the 26 patients with advanced solid tumors experienced stable disease for greater than six months. Three trials are now open for OMP-54F28 (FZD8-Fc) in combinations with standard therapy for pancreatic, ovarian and liver cancers, ...

ASCO: One step closer to a breath test for lung cancer

2014-05-31
Results of a University of Colorado Cancer Center study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) show that a test of organic compounds in exhaled breath can not only distinguish patients with lung cancer from patients with chronic obstructive pulmonary disease (COPD), but can also define the stage of any cancer present. "This could totally revolutionize lung cancer screening and diagnosis. The perspective here is the development of a non-traumatic, easy, cheap approach to early detection and differentiation of lung cancer," ...

ALK, ROS1 and now NTRK1: Study shows prevalence of new genetic driver in lung cancer

2014-05-31
A University of Colorado Cancer Center study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) draws a line from mutation of the gene NTRK1, to its role as an oncogene in non-small cell lung cancer, to treatment that targets this mutation. The current study reports the prevalence of the NTRK1 mutation in an unselected population of 450 lung cancer samples, with >1% percent of patients testing positive. This and other work from Dr. Doebele's group forms the basis of a phase 1 clinical trial targeting NTRK1 mutations in advanced solid ...

Patients with metastatic colon cancer respond to new combination therapy

Patients with metastatic colon cancer respond to new combination therapy
2014-05-31
CHICAGO — In an aggressive disease known for poor response rates, researchers from The University of Texas MD Anderson Cancer Center found patients with advanced colorectal cancer responded well to a combination therapy of the drugs vermurafenib, cetuximab and irinotecan. The Phase I trial, presented Saturday, May 31 in a poster discussion at the American Society of Clinical Oncology's 2014 Annual Meeting in Chicago, examines a specific mutation in the BRAF gene, which is present in 5 to 10 percent of colorectal cancer patients. Previous research identified this mutation ...

LAST 30 PRESS RELEASES:

Research on past hurricanes aims to reduce future risk

UT Health San Antonio, UTSA researchers receive prestigious 2025 Hill Prizes for medicine and technology

Panorama of our nearest galactic neighbor unveils hundreds of millions of stars

A chain reaction: HIV vaccines can lead to antibodies against antibodies

Bacteria in polymers form cables that grow into living gels

Rotavirus protein NSP4 manipulates gastrointestinal disease severity

‘Ding-dong:’ A study finds specific neurons with an immune doorbell

A major advance in biology combines DNA and RNA and could revolutionize cancer treatments

Neutrophil elastase as a predictor of delivery in pregnant women with preterm labor

NIH to lead implementation of National Plan to End Parkinson’s Act

Growth of private equity and hospital consolidation in primary care and price implications

Online advertising of compounded glucagon-like peptide-1 receptor agonists

Health care utilization and costs for older adults aging into Medicare after the affordable care act

Reading the genome and understanding evolution: Symbioses and gene transfer in leaf beetles

Brains of people with sickle cell disease appear older

Elena Belova and Yevgeny Raitses recognized for groundbreaking plasma physics research

SOX9 overexpression ameliorates metabolic dysfunction-associated steatohepatitis through activation of the AMPK pathway

Florescent probes illuminate cholesterol and Alzheimer’s research

Qigong significantly decreases chronic low back pain in US military veterans

New insights into pancreatic disease and diabetes

Effectiveness and safety of tenofovir amibufenamide in the treatment of chronic hepatitis B: A real-world, multicenter study

Higher costs limit attendance for life changing cardiac rehab

Over 500 patients receive diagnosis through genetic reanalysis

Brain changes in Huntington’s disease decades before diagnosis will guide future prevention trials

U of A astronomers capture unprecedented view of supermassive black hole in action

Astrophysicists reveal structure of 74 exocomet belts orbiting nearby stars in landmark survey

Textbooks need to be rewritten: RNA, not DNA, is the main cause of acute sunburn

Brits still associate working-class accents with criminal behavior – study warns of bias in the criminal justice system

What do you think ‘guilty’ sounds like? Scientists find accent stereotypes influence beliefs about who commits crimes

University of Calgary nursing study envisions child trauma treatment through a Marvel and DC lens

[Press-News.org] Reducing emissions will be the primary way to fight climate change, UCLA-led study finds
Climate engineering won't sufficiently stem global warming